Literature DB >> 2413142

Natural resistance to salmonellae in mice: control by genes within the major histocompatibility complex.

C E Hormaeche, K A Harrington, H S Joysey.   

Abstract

Determinations of 50% lethal dose (LD50) values in H-2 congenic B10 lines showed that late-emerging resistance (postimmune response phase) to salmonellae of intermediate virulence was less in H-2b and H-2d than in H-2a, H-2k, and H-2f mice. Association of resistance to H-2 was confirmed by backcross analysis, and LD50 determinations on H-2 recombinant haplotype strains showed that resistance maps to the I-E subregion. Bacterial growth curves in liver and spleen showed that susceptible mice carried bacteria for longer in the reticuloendothelial system than did resistant mice and that susceptible mice showed greater splenomegaly. Association of resistance and susceptibility to H-2 was not different when sister transductant salmonellae expressing somatic antigens O4 and O9 were used. Thus a gene(s) within the major histocompatibility complex controls natural resistance to salmonellae in mice by influencing the ability to clear bacteria from the reticuloendothelial system in the later phase of the infection, and the immunodominant O antigen cannot be solely involved.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413142     DOI: 10.1093/infdis/152.5.1050

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Role for neutrophils in host immune responses and genetic factors that modulate resistance to Salmonella enterica serovar typhimurium in the inbred mouse strain SPRET/Ei.

Authors:  Lien Dejager; Iris Pinheiro; Pieter Bogaert; Liesbeth Huys; Claude Libert
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

3.  Influence of different regions of the H-2 complex on the rate of clearance of Salmonella typhimurium.

Authors:  C Nauciel; E Ronco; M Pla
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 4.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

5.  Role of H-2 and non-H-2 genes in control of bacterial clearance from the spleen in Salmonella typhimurium-infected mice.

Authors:  C Nauciel; E Ronco; J L Guenet; M Pla
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

6.  T cells do not mediate the initial suppression of a Salmonella infection in the RES.

Authors:  C E Hormaeche; P Mastroeni; A Arena; J Uddin; H S Joysey
Journal:  Immunology       Date:  1990-06       Impact factor: 7.397

7.  SJL/J mice are highly susceptible to infection by mouse adenovirus type 1.

Authors:  K R Spindler; L Fang; M L Moore; G N Hirsch; C C Brown; A Kajon
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  Associations between malaria and MHC genes in a migratory songbird.

Authors:  Helena Westerdahl; Jonas Waldenström; Bengt Hansson; Dennis Hasselquist; Torbjörn von Schantz; Staffan Bensch
Journal:  Proc Biol Sci       Date:  2005-07-22       Impact factor: 5.349

9.  MHC heterozygosity confers a selective advantage against multiple-strain infections.

Authors:  Dustin J Penn; Kristy Damjanovich; Wayne K Potts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

10.  Chronic murine typhoid fever is a natural model of secondary hemophagocytic lymphohistiocytosis.

Authors:  Diane E Brown; Melissa W McCoy; M Carolina Pilonieta; Rebecca N Nix; Corrella S Detweiler
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.